121 related articles for article (PubMed ID: 12959433)
21. Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation.
Phi JH; Kim DG; Chung HT; Lee J; Paek SH; Jung HW
Cancer; 2009 Jan; 115(2):390-8. PubMed ID: 19109818
[TBL] [Abstract][Full Text] [Related]
22. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
[TBL] [Abstract][Full Text] [Related]
23. Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.
Nagato T; Katada A; Yoshizaki T; Kunibe I; Takahara M; Katayama A; Hayashi T; Harabuchi Y
Clin Neurol Neurosurg; 2010 Jul; 112(6):505-8. PubMed ID: 20303213
[TBL] [Abstract][Full Text] [Related]
24. Bilateral vestibular schwannomas in older patients: NF2 or chance?
Evans DG; Freeman S; Gokhale C; Wallace A; Lloyd SK; Axon P; Ward CL; Rutherford S; King A; Huson SM; Ramsden RT;
J Med Genet; 2015 Jun; 52(6):422-4. PubMed ID: 25725045
[TBL] [Abstract][Full Text] [Related]
25. Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma.
Morimoto M; Yoshioka Y; Kotsuma T; Adachi K; Shiomi H; Suzuki O; Seo Y; Koizumi M; Kagawa N; Kinoshita M; Hashimoto N; Ogawa K
Jpn J Clin Oncol; 2013 Aug; 43(8):805-12. PubMed ID: 23780990
[TBL] [Abstract][Full Text] [Related]
26. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
Zhao Y; Kumar RA; Baser ME; Evans DG; Wallace A; Kluwe L; Mautner VF; Parry DM; Rouleau GA; Joe H; Friedman JM
Genet Epidemiol; 2002 Oct; 23(3):245-59. PubMed ID: 12384977
[TBL] [Abstract][Full Text] [Related]
27. Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.
Mahboubi H; Maducdoc MM; Yau AY; Ziai K; Ghavami Y; Badran KW; Al-Thobaiti M; Brandon B; Djalilian HR
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):822-31. PubMed ID: 25791708
[TBL] [Abstract][Full Text] [Related]
28. [Surgical management of vestibular schwannomas secondary to type 2 neurofibromatosis].
Roche PH; Robitail S; Thomassin JM; Pellet W; Régis J
Neurochirurgie; 2004 Jun; 50(2-3 Pt 2):367-76. PubMed ID: 15179291
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2.
Subach BR; Kondziolka D; Lunsford LD; Bissonette DJ; Flickinger JC; Maitz AH
J Neurosurg; 1999 May; 90(5):815-22. PubMed ID: 10223445
[TBL] [Abstract][Full Text] [Related]
30. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
31. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
[TBL] [Abstract][Full Text] [Related]
32. Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients.
Rushing EJ; Olsen C; Mena H; Rueda ME; Lee YS; Keating RF; Packer RJ; Santi M
J Neurosurg; 2005 Dec; 103(6 Suppl):489-95. PubMed ID: 16383246
[TBL] [Abstract][Full Text] [Related]
33. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
34. [Neurofibromatosis type 2].
Gong S; Chen G; Zhong G; Yan K; Zhang E; Chen P; Lin N; Nie X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Aug; 20(16):721-3. PubMed ID: 17058913
[TBL] [Abstract][Full Text] [Related]
35. Gamma Knife surgery for nonvestibular schwannomas: radiological and clinical outcomes.
Elsharkawy M; Xu Z; Schlesinger D; Sheehan JP
J Neurosurg; 2012 Jan; 116(1):66-72. PubMed ID: 21962159
[TBL] [Abstract][Full Text] [Related]
36. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
37. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
[TBL] [Abstract][Full Text] [Related]
38. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
[TBL] [Abstract][Full Text] [Related]
39. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
40. Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas.
Massager N; Delbrouck C; Masudi J; De Smedt F; Devriendt D
B-ENT; 2013; 9(1):29-36. PubMed ID: 23641588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
